Pericardial Effusion and Cardiac Tamponade: Etiology and Evolution in the Contemporary Era
Carregando...
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2021
Título da Revista
ISSN da Revista
Título do Volume
Editora
Sociedade Brasileira de Cardiologia
Autores
Citação
INTERNATIONAL JOURNAL OF CARDIOVASCULAR SCIENCES, v.34, n.5 suppl 1, p.24-31, 2021
Resumo
Abstract Background: Pericardial effusion is a relatively common finding and can progress to cardiac tamponade; etiological diagnosis is important for guiding treatment decisions. With advances in medicine and improvement in the social context, the most frequent etiological causes have changed. Objectives: To evaluate the clinical and laboratory characteristics, etiology, and clinical course of patients with pericardial effusion and cardiac tamponade. Materials and methods: Patients with pericardial effusion classified as small (< 10 mm), moderate (between 10-20 mm), or severe (> 20 mm) were included. Data from the clinical history, physical examination, laboratory tests, and complementary tests were evaluated in patients with pericardial effusion and cardiac tamponade. The significance level was set at 5%. Results: A total of 254 patients with a mean age of 53.09 ± 17.9 years were evaluated, 51.2% of whom were female. A total of 40.4% had significant pericardial effusion (> 20 mm). Pericardial tamponade occurred in 44.1% of patients. Among pericardial effusion patients without tamponade, the most frequent etiologies were: idiopathic (44.4%) and postsurgical (17.6%), while among those with tamponade, the most frequent etiologies were postsurgical (21.4%) and postprocedural (19.6%). The mean follow-up time was 2.2 years. Mortality was 42% and 23.2 in those with and without tamponade, respectively (p=0.001). Conclusions: There is an etiological difference between pericardial effusion patients with and without cardiac tamponade. An idiopathic etiology is more common among those without tamponade, while postinterventional/postsurgical is more common among those with tamponade. The tamponade group had a higher mortality rate.
Palavras-chave
Pericardium, Pericarditis, Cardiac Tamponade/therapy, Pericardial Effusion/therapy
Referências
- Adler Y, 2015, EUR HEART J, V36, P2921, DOI 10.1093/eurheartj/ehv318
- Burazor I, 2013, CARDIOLOGY, V124, P224, DOI 10.1159/000348559
- COLOMBO A, 1988, CLIN CARDIOL, V11, P389, DOI 10.1002/clc.4960110606
- COREY GR, 1993, AM J MED, V95, P209, DOI 10.1016/0002-9343(93)90262-N
- Cornily JC, 2008, CARDIOLOGY, V111, P197, DOI 10.1159/000121604
- de Ceuninck M, 2013, ACTA CARDIOL, V68, P505, DOI 10.1080/AC.68.5.2994474
- Dequanter D, 2008, ANN SURG ONCOL, V15, P3268, DOI 10.1245/s10434-008-0059-z
- Fernandes F, 2016, Medicina cardiovascular: reduzindo o impacto das doenças, V2, P1297
- Garcia-Riego A, 2001, ACTA CYTOL, V45, P561, DOI 10.1159/000327865
- Gibbs CR, 2000, POSTGRAD MED J, V76, P809, DOI 10.1136/pmj.76.902.809
- Gornik HL, 2005, J CLIN ONCOL, V23, P5211, DOI 10.1200/JCO.2005.00.745
- Imazio M, 2007, CIRCULATION, V115, P2739, DOI 10.1161/CIRCULATIONAHA.106.662114
- Imazio M, 2010, CIRCULATION, V121, P916, DOI 10.1161/CIRCULATIONAHA.108.844753
- Kim SH, 2010, CANCER RES TREAT, V42, P210, DOI 10.4143/crt.2010.42.4.210
- Levy PY, 2003, MEDICINE, V82, P385, DOI 10.1097/01.md.0000101574.54295.73
- Mayosi BM, 2007, HEART, V93, P1176, DOI 10.1136/hrt.2007.127746
- Montera Marcelo Westerlund, 2013, Arq. Bras. Cardiol., V100, P01, DOI 10.5935/abc.2013S004
- Orbach A, 2016, [No title captured], P57
- Pêgo-Fernandes PM, 2019, Cirurgia torácica contemporânea, V1, P251
- Pêgo-Fernandes PM, 2019, Cirurgia torácica contemporânea, V1, P247
- Refaat MM, 2011, CLIN CARDIOL, V34, P593, DOI 10.1002/clc.20936
- Reuter H, 2006, QJM-INT J MED, V99, P827, DOI 10.1093/qjmed/hcl123
- Sagrista-Sauleda J, 2000, Am J Med, V109, P95